786 related articles for article (PubMed ID: 31178037)
1. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
Lin YT; Lu TS; Hansen RA; Wang CC
Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
[TBL] [Abstract][Full Text] [Related]
2. Serious arrhythmia in initiators of citalopram, escitalopram, and other selective serotonin reuptake inhibitors: A population-based cohort study in older adults.
Aakjaer M; Werther SK; De Bruin ML; Andersen M
Clin Transl Sci; 2022 Sep; 15(9):2105-2115. PubMed ID: 35733364
[TBL] [Abstract][Full Text] [Related]
3. Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population.
Kaplan C; Zhang Y
J Ment Health Policy Econ; 2012 Dec; 15(4):171-8. PubMed ID: 23525835
[TBL] [Abstract][Full Text] [Related]
4. Escitalopram versus other antidepressive agents for depression.
Cipriani A; Santilli C; Furukawa TA; Signoretti A; Nakagawa A; McGuire H; Churchill R; Barbui C
Cochrane Database Syst Rev; 2009 Apr; (2):CD006532. PubMed ID: 19370639
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of selective serotonin reuptake inhibitors and fall risk in older adults.
Haddad YK; Kakara R; Marcum ZA
J Am Geriatr Soc; 2022 May; 70(5):1450-1460. PubMed ID: 35132611
[TBL] [Abstract][Full Text] [Related]
6. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events.
Czaja AS; Valuck RJ; Anderson HD
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):607-14. PubMed ID: 23456956
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A
CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445
[TBL] [Abstract][Full Text] [Related]
8. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
Sanchez C; Reines EH; Montgomery SA
Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database.
Coupland C; Hill T; Morriss R; Moore M; Arthur A; Hippisley-Cox J
BMJ; 2016 Mar; 352():i1350. PubMed ID: 27005565
[TBL] [Abstract][Full Text] [Related]
11. Escitalopram.
Aronson S; Delgado P
Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
[TBL] [Abstract][Full Text] [Related]
12. Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database.
Billioti de Gage S; Collin C; Le-Tri T; Pariente A; Bégaud B; Verdoux H; Dray-Spira R; Zureik M
CNS Drugs; 2018 Jul; 32(7):673-684. PubMed ID: 29959758
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of action of antidepressants: new data from Escitalopram].
Fabre V; Hamon M
Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
[TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Breast Cancer Res; 2018 Jan; 20(1):4. PubMed ID: 29351761
[TBL] [Abstract][Full Text] [Related]
15. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
[TBL] [Abstract][Full Text] [Related]
17. Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication.
Tamblyn R; Bates DW; Buckeridge DL; Dixon WG; Girard N; Haas JS; Habib B; Iqbal U; Li J; Sheppard T
J Am Geriatr Soc; 2020 Jul; 68(7):1494-1503. PubMed ID: 32181493
[TBL] [Abstract][Full Text] [Related]
18. Increased Odds of Ventricular Arrhythmias Associated with Selective Serotonin Reuptake Inhibitor Use among the Pediatric and Young Adult Population: A Case-Control Study.
Czaja AS; Anderson HD; Ghosh D; Davidson J; Campbell JD; Valuck RJ
J Pediatr; 2020 Nov; 226():173-178.e8. PubMed ID: 32645405
[TBL] [Abstract][Full Text] [Related]
19. Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV.
Caballero J; Nahata MC
Ann Pharmacother; 2005 Jan; 39(1):141-5. PubMed ID: 15562140
[TBL] [Abstract][Full Text] [Related]
20. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Assimon MM; Brookhart MA; Flythe JE
J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
